Mailing of the Meeting materials has commenced, and Quorum Shareholders should receive them in due course. All of the Meeting materials can be accessed on Quorum’s corporate website ( ...

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...

Johnson & Johnson has kicked off a marketing application in the US for TAR-200 as a treatment for a form of bladder cancer, using a novel technology that releases the drug intravesically, or directly ...